Universitätsklinikum Schleswig-Holstein (UKSH)

Preface (2015) Hauschild A, Koelbl O, Mackensen A, Schadendorf D Journal article, Editorial Giant cell arteritis: Diagnostic accuracy of mr imaging of superficial cranial arteries in initial diagnosis-results from a multicenter trial (2014) Klink T, Geiger J, Both M, Ness T, Heinzelmann S, Reinhard M, Holl-Ulrich K, et al. Journal article Nilotinib in combination with carboplatin and paclitaxel is a candidate for ovarian cancer treatment (2014) Weigel MT, Rath K, Alkatout I, Wenners AS, Schem C, Maass N, Jonat W, Mundhenke C Journal article MRI displays involvement of the temporalis muscle and the deep temporal artery in patients with giant cell arteritis (2014) Veldhoen S, Klink T, Geiger J, Vaith P, Glaser C, Ness T, Duwendag D, et al. Journal article Impact of radical operative treatment on the quality of life in women with vulvar cancer - A retrospective study (2014) Guenther V, Malchow B, Schubert M, Andresen L, Jochens A, Jonat W, Mundhenke C, Alkatout I Journal article Massive blood transfusion after the first cut in liver transplantation predicts renal outcome and survival (2014) Reichert B, Kaltenborn A, Becker T, Schiffer M, Klempnauer J, Schrem H Journal article Accuracy of trabecular structure by HR-pQCT compared to gold standard ?CT in the radius and tibia of patients with osteoporosis and long-term bisphosphonate therapy (2014) Krause M, Museyko O, Breer S, Wulff B, Duckstein C, Vettorazzi E, Glueer C, et al. Journal article Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib (2014) Hanfstein B, Shlyakhto V, Lauseker M, Hehlmann R, Saussele S, Dietz C, Erben P, et al. Journal article Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors: a multicenter phase 2 trial (AGO-GYN5) (2014) Emons G, Gorchev G, Harter P, Wimberger P, Staehle A, Hanker L, Hilpert F, et al. Journal article Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)+ (2014) Von Minckwitz G, Loibl S, Untch M, Eidtmann H, Rezai M, Fasching P, Tesch H, et al. Journal article